Neuroprotective Effects of Cistanches Herba Therapy on Patients with Moderate Alzheimer’s Disease

Figure 3

T-tau, TNF-α, and IL-1β mRNA expressions in the CSF of AD patients evaluated by RT-PCR. The mRNA expressions of T-tau ((a), 188 bp), TNF-α ((b), 560 bp), and IL-1β ((c), 298 bp) from AD patients’ CSF, GAPDH (100 bp). 1: DON treatment group; 2: CH treatment group; 3: control group. For (d)–(f): the relative changes in mRNA expressions of T-tau, TNF-α, and IL-1β. The mRNA expressions of T-tau, TNF-α, and IL-1β had reduced during 48 weeks compared with control group after drug treatments (). There was no statistical deviation between DON treatment group and CH treatment group (). M: marker.

(a)

(b)

(c)

(d)

(e)

(f)